(Q51021337)

27 March 2018

title

Treatment with recombinant human erythropoietin in children with malignancies (English)

1 reference

27 March 2018

1 reference

Bolonaki I

1

1 reference

27 March 2018

Stiakaki E

2

1 reference

27 March 2018

Lydaki E

3

1 reference

27 March 2018

Dimitriou H

4

1 reference

27 March 2018

Kambourakis A

5

1 reference

27 March 2018

Kalmantis T

6

1 reference

27 March 2018

Kalmanti M

7

1 reference

27 March 2018

publication date

1 March 1996

1 reference

27 March 2018

Pediatric Hematology and Oncology

published in

1 reference

27 March 2018

volume

13

1 reference

27 March 2018

issue

2

1 reference

27 March 2018

page(s)

111-121

1 reference

27 March 2018

Hematologic manifestations of malignancy

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

Regional assignment of the erythropoietin gene to human chromosome region 7pter----q22.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

Cloning and expression of the human erythropoietin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

Recombinant human erythropoietin and the anemia of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

Eight-drugs-in-one-day chemotherapy in postirradiated adult patients with malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019609030801

10.3109/08880019609030801

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018